Increased interleukin-27 promotes Th1 differentiation in patients with chronic immune thrombocytopen

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户:xiaoxiaolong1314
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background Chronic immune thrombocytopenia (cITP) is an autoimmune disease with disturbed cytokine profile.Although plasma levels of IL-27 are shown to be associated with cITP,its association with T cell subsets has not been studied.The Objective of the present study was to study the association between IL-27 and different T cell subsets in cITP patients.
其他文献
Objective To observe the clinical safety and efficacy of decitabine in patients of acute myeloid leukemia and myelodysplastic syndromes.Methods Totally 79 patients with MDS/AML were divided into three
会议
Objective To detect the level of MDS / AML patients treated with decitabine and study the relationship between the level of DNA methylation in the tumor cells of MDS / AML and decitabine.To discuss th
会议
Background Acute myeloid leukemia (AML) is generally regarded as a disorder of stem cells,known as leukemic initiating cells (LICs),which initiate the disease and contribute to relapses.Although the p
会议
Background In acute myeloid leukemia (AML),the leukemia initiating cells (LICs) or leukemia stem cells (LSCs) is found within the CD34+CD38- cell compartment.The LICs subpopulation survives chemothera
会议
Objective Aberrant expression of SRY-box containing gene 17 (SOX17) has been observed in several solid tumors.However,little is known about SOX17 expression in acute myeloid leukemia(AML).The purpose
会议
Objective To improve the recognization of myeloid/natural killer (NK) cell precursor acute leukemia.Methods A case of myeloid/NK cell precursor acute leukemia was reported.Results Myeloid/NK cell prec
会议
Objective To study the desialylation status of platelets in immune thrombocytopenia (ITP) and evaluate its association with anti-platelet autoantibody specificity and patients response to therapies.
会议
The purpose of this study was to compare the effects of different dosages of intravenous immunoglobulin (IVIg) for treatment of immune thrombocytopenia.A total of 167 eligible patients were included a
会议
Background Immune thrombocytopenia (ITP) is an autoimmune disorder in which the patients immune system is activated by platelet autoantigens resulting in immune-mediated platelet destruction and/or su
会议
Background.The spleen in immune thrombocytopenic purpura (ITP) patients is an important source of anti-platelet antibodies and the major site of platelet destruction.Splenectomy is the only treatment
会议